Publications/Presentations

PUBLICATIONS

Student co-authors underlined, High school co-authors indicated by an (*)

  1. Shana V. Stoddard, Felissa E. Wallace*, Serena D. Stoddard, Qianyi Cheng, Daniel Acosta, Shaliz Barzani, Marissa Bobay, Jared BriantChristian CisnerosSamantha Feinstein, Kelsey GlasperMunazza Hussain Abigail LidoskiPranay LingareddyGrace LovettLeslie MatherneJackson McIntoshNikita Moonsani, Lia NageeKudzai NyamkondiwaIsaiah PrattEmma RootMary Rose RutledgeMackenzie SawyerYash Singh, Kristiana SmithUbaid Tanveer, and Sona Vaghela. In silico design of peptide-based SARS-CoV-2 fusion inhibitors that target WT and mutant versions of SARS-CoV-2 HR1 domains. Biophysica, 2021, 1(3), 311-327
  2. Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site. Shana V. Stoddard, Serena D. Stoddard, Benjamin K. Oelkers, Kennedi Fitts, Kellen Whalum, Kaylah Whalum, Alexander D. Hemphill, Jithin Manikonda, Linda Michelle Martinez, Elizabeth G. Riley, Caroline M. Roof, Nowreen Sarwar, Doni M. Thomas, Emily Ulmer, Felissa E. Wallace*, Pankaj Pandey, and Sudeshna Roy. Viruses, (2020), 12, 942 DOI: 10.3390/v12090942
  3. Design and Synthesis of Diazine-based Panobinostat Analogues for HDAC8 Inhibition.Sivaraman Balasubramaniam, Sajith Vijayan, Liam GoldmanXavier A. May, Kyra Dodson, Sweta Adhikari, Fatima Rivas, Davita L. Watkins, and Shana V. Stoddard. Beilstein Journal of Organic Chemistry (2020) 16, 628-637 DOI: 10.3762/bjoc.16.59
  4. In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity. Shana V. Stoddard, Kyra Dodson, Kamesha Adams, and Davita L. Watkins. International Journal of Molecular Science (2020) 21(1), 219 DOI: 10.3390/ijms21010219
  5. Variable In Vivo Expression of Disiaganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Determined Using Positron Emission Tomography. Elizabeth R. Butch, Paul E. Mead, Victor Amador-Diaz, Heather Tillman, Elizabeth Stewart, Jitendra K. Mishra, Jieun Kim, Armita Bahrami, Jason L.J. Dearling, Alan B. Packard, Shana V. Stoddard, Amy L.Vāvere, Yuanyuan Han, Barry L. Shulkin, and Scott E. Snyder. Cancer Research (2019) 79: 1-13; DOI: 10.1158/0008-5472.can-18-3340 
  6. Structure and Function Insights Garnered from In silico Modelling of the Thrombospondin Type-1 Domain-Containing 7A Antigen. Shana V. StoddardColin L. WelshMaggie M. PalopoliSerena D. StoddardMounika P. AramandlaRiya M. Patel, and Laurence H. Beck, Jr. PROTEINS: Structure, Function, Bioinformatics.  Proteins. (2019) 87(2) 136-145 DOI: 10.1002/prot.25640
  7. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between Histone Deacetylase 2 (HDAC2) and Histone Deacetylase 8 (HDAC8) Shana V. Stoddard, Xavier A. May, Fatima Rivas, Kyra Dodson, Sajith Vijayan, Swetha Adhika, Kordarius Parker, Davita L. Watkins.  Molecular Informatics (2018) 38(3) 1800080; DOI: 10.1002/minf.201800080
  8. Insights and Ideas Garnered from Marine Metabolites for Development of Acetylcholinesterase and Amyloid-β Aggregation Inhibitors, Shana V. Stoddard, Mark T. Hamann, Randy M. Wadkins, Marine Drugs (2014) 12, 2114-2131; DOI: 10.3390/md12042114
  9. In Silico Design and Evaluation of Carboxylesterase Inhibitors, Shana V. Stoddard, Xiaozhen Yu, Philip M. Potter, Randy M. Wadkins. Journal of Pesticide Science (2010) 35, 240-249; DOI:10.1584/jpestics.r10-06
  10. Improved, Selective, Human Intestinal Carboxylesterase Inhibitors Designed to Modulate CPT-11 Toxicity, Latorya D. Hicks, Janice L. Hyatt, Shana Stoddard, Lyudmila Tsurkan, Carol C. Edward, Monika Wierdl, Randy M. Wadkins, Philip M. Potter. Journal of Medicinal Chemistry (2009) 52, 3742-3752; DOI: 10.1021/jm9001296

SELECTED PRESENTATIONS

  1. Shana V. Stoddard and Carmella N. Stoddard, The Benefits of Enlightenment?: A Strategic Pedagogy for Explicitly Teaching about Diversity and Equity in STEM Classrooms. American Chemical Society, Oral talk (April 2021)
  2. Adrian Russ, Benjamin Oelkers, Felissa E. Wallace*, Serena D. Stoddard, Qianyi Yi, and Shana V. Stoddard. Protein engineering and optimization of peptide-based therapeutics as RBD binding coronavirus antivirals. American Chemical Society (April 2021)
  3. Felissa E. Wallace*, Serena D. Stoddard, Adrian Russ, Benjamin Oelkers, Qianyi Yi, and Shana V. Stoddard. Protein engineering and optimization of peptide-based therapeutics as HR1 binding coronavirus antivirals. American Chemical Society (April 2021)
  4. Kaylah Whalum, Kathryn Edwards, Qianyi Yi, Serena D. Stoddard, Guadalupe Calderon, Nicole Luthcke, Keerthana Kasetty, and Shana V. Stoddard. Modeling, Characterization, and Classification of Human Thrombospondin Type-1 Like Domains: Evidence for TRP Ladder Functionalization Based on Ladder Type? American Chemical Society (April 2021)
  5. Arrington Moses, Ayanna Kemp, Kelsey Glasper, Kennedi Fitts, Brandon James, Liam Goldman, Xavier May, and Shana V. Stoddard. Developing the perfect fit: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitors for Anti-cancer, Neurological and Autoimmune Therapies. American Chemical Society (April 2021)
  6. Ayanna Kemp, Arrington Moses, Kelsey Glasper, Kennedi Fitts, Brandon James, Liam Goldman, Xavier May, and Shana V. Stoddard. Developing the perfect fit: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitors for Anti-cancer, Neurological and Autoimmune Therapies. National Conference on Undergraduate Research. Bozeman, MT (April 2021)
  7. Keerthana Kasetty, Kathryn Edwards, Qianyi Yi, Serena D. Stoddard, Guadalupe Calderon, Nicole Luthcke, Kaylah Whalum, and Shana V. Stoddard. Modeling, Characterization, and Classification of Human Thrombospondin Type-1 Like Domains: Evidence for TRP Ladder Functionalization Based on Ladder Type? National Conference on Undergraduate Research. Bozeman, MT (April 2021)
  8. Benjamin Oelkers, Felissa E. Wallace*, Adrian Russ, Serena D. Stoddard, Qianyi Yi, and Shana V. Stoddard. Protein engineering and optimization of peptide-based therapeutics as dual site binding coronavirus antivirals National Conference on Undergraduate Research. Bozeman, MT (April 2021)
  9. Shana V. Stoddard, Serena D. Stoddard, Benjamin K. Oelkers, Kennedi Fitts, Kellen Whalum, Kaylah Whalum, Alexander D. Hemphill, Jithin Manikonda, Linda Michelle Martinez, Elizabeth G. Riley, Caroline M. Roof, Nowreen Sarwar, Doni M. Thomas, Emily Ulmer, Felissa E. Wallace*, Pankaj Pandey and Sudeshna Roy, Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site. National Conference on Undergraduate Research. Bozeman, MT (April 2021)
  10. Shana V. Stoddard Molecular Immunotherapeutics Research: Advances in Autoimmnue, Anticancer, and Antiviral Therapeutics. Invited Talk, University of Memphis, Memphis, TN (November 2020)
  11. Jeremy Thelven, Liam Goldman, Shana V. Stoddard, Roberto de la Salud Bea. Design, Synthesis, and Effect of Diarylcyclopropane hydroxamic Acids as Histone Deacetylase (HDAC) Inhibitors: Improving Possible Therapy for Huntington’s disease. 46th ACS National Organic Symposium, Bloomington, IN (June 2019)
  12. Colin Welsh and Shana V. Stoddard. In silico Prediction of Immunogenic Sites on PMN Antigen and Design of Epitope Blocking Caps. American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  13. Serena D. Stoddard and Shana V. Stoddard. New tools for autoimmune kidney disease: Design of antigen binding proteins against the thrombospondin type-1 containing domain 7A. American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  14. Omar Stocks, Liam Goldman, and Shana V. Stoddard. Development of Antigen Binding Protein Monobodies as a Tool for Antigen Specific Treatment for Autoimmune Kidney Disease. American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  15. Liam Goldman, Omar Stocks, and Shana V. Stoddard. Epitope Characterization and Design of Epitope Binding Proteins for Idiopathic Membranous Nephropathy: New Tools for Autoimmune Kidney Disease Therapy American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  16. Itthipoaln Rasasack and Shana V. Stoddard. Development of antigen-specific blocking monobodies against the β2-glycoprotein I receptor for the inhibition of systemic lupus erythematosus. American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  17. Aryan Galani and Shana V. Stoddard. Design of antibody-blocking monobodies: A novel therapeutic approach for autoimmune kidney disease. American Society for Biochemistry and Molecular Biology Annual National Meeting. Orlando, FL (April 2019)
  18. Serena D. Stoddard and Shana V. Stoddard. New tools for autoimmune kidney disease. Design of antigen binding proteins against the thrombospondin type-1 containing domain 7A. Annual Biomedical Research Conference for Minority Students, Indianapolis, IN (November 2018)
  19. Shana V. Stoddard. Computational Insights into the Structure and Epitope locations for Two Idiopathic Membranous Nephropathy Antigens: Phospholipase A2 Receptor and the Thrombospondin Type-1 Containing Domain 7A and Design of Antigen Binding Proteins. American Society for Biochemistry and Molecular Biology Annual National Meeting. San Diego, CA (April 2018
  20. Barry Rich, Emma Goldman, Caylon Martin*,Shana V. Stoddard, Kimberly A. Brien. Synthesis and Computational Evaluation of Vorinostat Boron Derivatives as Potential Histone Deacetylase Inhibitors. 255th ACS National Meeting, New Orleans, LA (March 2018)